Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
Apax Global Alpha
“Hidden Gems” strategy: green shoots into live deals
23rd Nov 2023
Surface Transforms
Funding for growth: Open Offer
22nd Nov 2023
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Services for private Companies
Tax enhanced research
Product reports for investors and advisors.
Bespoke consulting services
Bespoke services
Services for clients with specific needs
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
86: Investing in consumer companies and finding out what consumers really want | Phoebe Scriven of VGC Partners
Stay up-to-date with the latest research
Sign up to our newsletter
Latest research
Our research can still be accessed for free under MIFID II.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax enhanced research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
Tissue Regenix
Life Sciences
Continuation of the positive momentum
By
Dr Martin Hall
18 Sep 2023
The International Stock Exchange
Financials
Strong first-half performance
By
Jason Streets
13 Sep 2023
The Monthly: September 2023
01 Sep 2023
Real Estate Credit Investments (RECI)
Investment Companies
Why CRE equity worries should not apply to RECI
By
Mark Thomas
30 Aug 2023
H&T Group
Financials
Delivering the pawnbroking growth opportunity
By
Mark Thomas
25 Aug 2023
Financials
Equity Income – UK or Global?
By
Riccardo Bindi
17 Aug 2023
Renewables
UK interest rates and “risk-free” gilts at their peak?
By
Nigel Hawkins
09 Aug 2023
Arbuthnot Banking Group Plc
Financials
1H’23: steering through the interest rate wave
By
Mark Thomas
04 Aug 2023
The Monthly August 2023
01 Aug 2023
City of London Investment Group
Investment Companies
Positive markets offset by revenue margins
By
Dr Brian Moretta
01 Aug 2023
Shield Therapeutics Plc
Life Sciences
Accrufer Rx momentum gathering
By
Dr Martin Hall
25 Jul 2023
Prev
1
2
3
4
5
...
77
Next
